Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Lièvre A, Ouine B, Canet J, Cartier A, Amar Y, Cacheux W, Mariani O, Guimbaud R, Selves J, Lecomte T, Guyetant S, Bieche I, Berger F, de Koning L.

Br J Cancer. 2018 Jun 14. doi: 10.1038/s41416-018-0130-x. [Epub ahead of print]

PMID:
29899390
2.

Beef tenderness and intramuscular fat proteomic biomarkers: muscle type effect.

Picard B, Gagaoua M, Al-Jammas M, De Koning L, Valais A, Bonnet M.

PeerJ. 2018 Jun 7;6:e4891. doi: 10.7717/peerj.4891. eCollection 2018.

3.

Correction to "Stoichiometry, Absolute Abundance, and Localization of Proteins in the Bacillus cereus Spore Coat Insoluble Fraction Determined Using a QconCAT Approach".

Stelder SK, Benito de Moya C, Hoefsloot HCJ, de Koning LJ, Brul S, de Koster CG.

J Proteome Res. 2018 Jul 6;17(7):2562. doi: 10.1021/acs.jproteome.8b00313. Epub 2018 Jun 1. No abstract available.

PMID:
29856629
4.

LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers.

Maubant S, Tahtouh T, Brisson A, Maire V, Némati F, Tesson B, Ye M, Rigaill G, Noizet M, Dumont A, Gentien D, Marty-Prouvost B, de Koning L, Mahmood SF, Decaudin D, Cruzalegui F, Tucker GC, Roman-Roman S, Dubois T.

Oncotarget. 2018 Apr 27;9(32):22586-22604. doi: 10.18632/oncotarget.25187. eCollection 2018 Apr 27.

5.

"One-Pot" Sample Processing Method for Proteome-Wide Analysis of Microbial Cells and Spores.

Swarge BN, Roseboom W, Zheng L, Abhyankar WR, Brul S, de Koster CG, de Koning LJ.

Proteomics Clin Appl. 2018 Feb 27:e1700169. doi: 10.1002/prca.201700169. [Epub ahead of print]

PMID:
29484825
6.

Involvement of the FOXO6 transcriptional factor in breast carcinogenesis.

Lallemand F, Petitalot A, Vacher S, de Koning L, Taouis K, Lopez BS, Zinn-Justin S, Dalla-Venezia N, Chemlali W, Schnitzler A, Lidereau R, Bieche I, Caputo SM.

Oncotarget. 2017 Dec 30;9(7):7464-7475. doi: 10.18632/oncotarget.23779. eCollection 2018 Jan 26.

7.

Reverse phase protein arrays for the identification/validation of biomarkers of beef texture and their use for early classification of carcasses.

Gagaoua M, Bonnet M, Ellies-Oury MP, De Koning L, Picard B.

Food Chem. 2018 Jun 1;250:245-252. doi: 10.1016/j.foodchem.2018.01.070. Epub 2018 Jan 10.

PMID:
29412918
8.

Stoichiometry, Absolute Abundance, and Localization of Proteins in the Bacillus cereus Spore Coat Insoluble Fraction Determined Using a QconCAT Approach.

Stelder SK, Benito de Moya C, Hoefsloot HCJ, de Koning LJ, Brul S, de Koster CG.

J Proteome Res. 2018 Feb 2;17(2):903-917. doi: 10.1021/acs.jproteome.7b00732. Epub 2018 Jan 4. Erratum in: J Proteome Res. 2018 Jul 6;17(7):2562.

9.

Stabilizing specimens for routine ammonia testing in the clinical laboratory.

Gifford JL, Nguyen WNT, de Koning L, Seiden-Long I.

Clin Chim Acta. 2018 Mar;478:37-43. doi: 10.1016/j.cca.2017.12.022. Epub 2017 Dec 16.

PMID:
29258744
10.

[Hypersensitivity reactions and vaccines].

Geersing TH, Hilgersom WJA, Tempels-Pavlica Ž, Rümke HC, de Koning LCMJ, Borgsteede SD.

Ned Tijdschr Geneeskd. 2017;161(0):D1491. Dutch.

PMID:
29219793
11.

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Lièvre A, Ouine B, Canet J, Cartier A, Amar Y, Cacheux W, Mariani O, Guimbaud R, Selves J, Lecomte T, Guyetant S, Bieche I, Berger F, de Koning L.

Br J Cancer. 2017 Dec 5;117(12):1819-1827. doi: 10.1038/bjc.2017.353. Epub 2017 Oct 12. Erratum in: Br J Cancer. 2018 Jun 14;:.

12.

IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer.

Neuzillet Y, Chapeaublanc E, Krucker C, De Koning L, Lebret T, Radvanyi F, Bernard-Pierrot I.

BMC Cancer. 2017 Sep 7;17(1):636. doi: 10.1186/s12885-017-3618-5.

13.

Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma.

Biau J, Chautard E, De Koning L, Court F, Pereira B, Verrelle P, Dutreix M.

Radiat Oncol. 2017 Jul 28;12(1):123. doi: 10.1186/s13014-017-0858-0.

14.

Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation.

Pérez-Martínez P, Mikhailidis DP, Athyros VG, Bullo M, Couture P, Covas MI, de Koning L, Delgado-Lista J, Díaz-López A, Drevon CA, Estruch R, Esposito K, Fitó M, Garaulet M, Giugliano D, García-Ríos A, Katsiki N, Kolovou G, Lamarche B, Maiorino MI, Mena-Sánchez G, Muñoz-Garach A, Nikolic D, Ordovás JM, Pérez-Jiménez F, Rizzo M, Salas-Salvadó J, Schröder H, Tinahones FJ, de la Torre R, van Ommen B, Wopereis S, Ros E, López-Miranda J.

Nutr Rev. 2017 May 1;75(5):307-326. doi: 10.1093/nutrit/nux014.

15.

Acceleration-based training: A new mode of training in senescent rats improving performance and left ventricular and muscle functions.

Launay T, Momken I, Carreira S, Mougenot N, Zhou XL, De Koning L, Niel R, Riou B, Billat V, Besse S.

Exp Gerontol. 2017 Sep;95:71-76. doi: 10.1016/j.exger.2017.05.002. Epub 2017 May 4.

PMID:
28479388
16.

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro.

Rebouissou S, La Bella T, Rekik S, Imbeaud S, Calatayud AL, Rohr-Udilova N, Martin Y, Couchy G, Bioulac-Sage P, Grasl-Kraupp B, de Koning L, Ganne-Carrié N, Nault JC, Ziol M, Zucman-Rossi J.

Clin Cancer Res. 2017 Aug 1;23(15):4364-4375. doi: 10.1158/1078-0432.CCR-16-3118. Epub 2017 Feb 28.

PMID:
28246274
17.

Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma.

Tranchant R, Quetel L, Tallet A, Meiller C, Renier A, de Koning L, de Reynies A, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, Jean D.

Clin Cancer Res. 2017 Jun 15;23(12):3191-3202. doi: 10.1158/1078-0432.CCR-16-1971. Epub 2016 Dec 21.

18.

Critically High Plasma Ammonia in an Adolescent Girl.

Orton DJ, Gifford JL, Seiden-Long I, Khan A, de Koning L.

Clin Chem. 2016 Dec;62(12):1565-1568. No abstract available.

19.

Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study.

Samuels S, Balint B, von der Leyen H, Hupé P, de Koning L, Kamoun C, Luscap-Rondof W, Wittkop U, Bagrintseva K, Popovic M, Kereszt A, Berns E, Kenter GG, Jordanova ES, Kamal M, Scholl S.

Br J Cancer. 2016 Dec 6;115(12):1575-1583. doi: 10.1038/bjc.2016.340. Epub 2016 Nov 22.

20.

Serum Total 25-OH Vitamin D Adds Little Prognostic Value in Patients Undergoing Coronary Catheterization.

Gerling ME, James MT, Wilton SB, Naugler C, Southern DA, Galbraith PD, Knudtson M, de Koning L.

J Am Heart Assoc. 2016 Oct 21;5(10). pii: e004289.

21.

The Influence of Sporulation Conditions on the Spore Coat Protein Composition of Bacillus subtilis Spores.

Abhyankar WR, Kamphorst K, Swarge BN, van Veen H, van der Wel NN, Brul S, de Koster CG, de Koning LJ.

Front Microbiol. 2016 Oct 13;7:1636. eCollection 2016.

22.

Global Conservation of Protein Status between Cell Lines and Xenografts.

Biau J, Chautard E, Court F, Pereira B, Verrelle P, Devun F, De Koning L, Dutreix M.

Transl Oncol. 2016 Aug;9(4):313-21. doi: 10.1016/j.tranon.2016.05.005.

23.

Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma.

Carita G, Frisch-Dit-Leitz E, Dahmani A, Raymondie C, Cassoux N, Piperno-Neumann S, Némati F, Laurent C, De Koning L, Halilovic E, Jeay S, Wylie A, Emery C, Roman-Roman S, Schoumacher M, Decaudin D.

Oncotarget. 2016 Jun 7;7(23):33542-56. doi: 10.18632/oncotarget.9552.

24.

Maternal Whole Blood Gene Expression at 18 and 28 Weeks of Gestation Associated with Spontaneous Preterm Birth in Asymptomatic Women.

Heng YJ, Pennell CE, McDonald SW, Vinturache AE, Xu J, Lee MW, Briollais L, Lyon AW, Slater DM, Bocking AD, de Koning L, Olson DM, Dolan SM, Tough SC, Lye SJ.

PLoS One. 2016 Jun 22;11(6):e0155191. doi: 10.1371/journal.pone.0155191. eCollection 2016.

25.

'Omics' for microbial food stability: Proteomics for the development of predictive models for bacterial spore stress survival and outgrowth.

Abhyankar W, Stelder S, de Koning L, de Koster C, Brul S.

Int J Food Microbiol. 2017 Jan 2;240:11-18. doi: 10.1016/j.ijfoodmicro.2016.05.008. Epub 2016 May 7. Review.

PMID:
27296564
26.

LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers.

Prunier C, Josserand V, Vollaire J, Beerling E, Petropoulos C, Destaing O, Montemagno C, Hurbin A, Prudent R, de Koning L, Kapur R, Cohen PA, Albiges-Rizo C, Coll JL, van Rheenen J, Billaud M, Lafanechère L.

Cancer Res. 2016 Jun 15;76(12):3541-52. doi: 10.1158/0008-5472.CAN-15-1864. Epub 2016 May 23.

27.

Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer.

Meseure D, Vacher S, Lallemand F, Alsibai KD, Hatem R, Chemlali W, Nicolas A, De Koning L, Pasmant E, Callens C, Lidereau R, Morillon A, Bieche I.

Br J Cancer. 2016 Jun 14;114(12):1395-404. doi: 10.1038/bjc.2016.123. Epub 2016 May 12.

28.

Consensus on precision medicine for metastatic cancers: a report from the MAP conference.

Swanton C, Soria JC, Bardelli A, Biankin A, Caldas C, Chandarlapaty S, de Koning L, Dive C, Feunteun J, Leung SY, Marais R, Mardis ER, McGranahan N, Middleton G, Quezada SA, Rodón J, Rosenfeld N, Sotiriou C, André F.

Ann Oncol. 2016 Aug;27(8):1443-8. doi: 10.1093/annonc/mdw192. Epub 2016 May 3.

PMID:
27143638
29.

Arpin downregulation in breast cancer is associated with poor prognosis.

Lomakina ME, Lallemand F, Vacher S, Molinie N, Dang I, Cacheux W, Chipysheva TA, Ermilova VD, de Koning L, Dubois T, Bièche I, Alexandrova AY, Gautreau A.

Br J Cancer. 2016 Mar 1;114(5):545-53. doi: 10.1038/bjc.2016.18. Epub 2016 Feb 11.

30.

AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin.

Couderc C, Boin A, Fuhrmann L, Vincent-Salomon A, Mandati V, Kieffer Y, Mechta-Grigoriou F, Del Maestro L, Chavrier P, Vallerand D, Brito I, Dubois T, De Koning L, Bouvard D, Louvard D, Gautreau A, Lallemand D.

Neoplasia. 2016 Jan;18(1):10-24. doi: 10.1016/j.neo.2015.11.010.

31.

Bacillus subtilis Spore Inner Membrane Proteome.

Zheng L, Abhyankar W, Ouwerling N, Dekker HL, van Veen H, van der Wel NN, Roseboom W, de Koning LJ, Brul S, de Koster CG.

J Proteome Res. 2016 Feb 5;15(2):585-94. doi: 10.1021/acs.jproteome.5b00976. Epub 2016 Jan 13.

PMID:
26731423
32.

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.

Michaut M, Chin SF, Majewski I, Severson TM, Bismeijer T, de Koning L, Peeters JK, Schouten PC, Rueda OM, Bosma AJ, Tarrant F, Fan Y, He B, Xue Z, Mittempergher L, Kluin RJ, Heijmans J, Snel M, Pereira B, Schlicker A, Provenzano E, Ali HR, Gaber A, O'Hurley G, Lehn S, Muris JJ, Wesseling J, Kay E, Sammut SJ, Bardwell HA, Barbet AS, Bard F, Lecerf C, O'Connor DP, Vis DJ, Benes CH, McDermott U, Garnett MJ, Simon IM, Jirström K, Dubois T, Linn SC, Gallagher WM, Wessels LF, Caldas C, Bernards R.

Sci Rep. 2016 Jan 5;6:18517. doi: 10.1038/srep18517.

33.

Risk prediction models for acute kidney injury following major noncardiac surgery: systematic review.

Wilson T, Quan S, Cheema K, Zarnke K, Quinn R, de Koning L, Dixon E, Pannu N, James MT.

Nephrol Dial Transplant. 2016 Feb;31(2):231-40. doi: 10.1093/ndt/gfv415. Epub 2015 Dec 24. Review.

PMID:
26705194
34.

Sensitivity and Specificity of Community Fecal Immunotesting Screening for Colorectal Carcinoma in a High-Risk Canadian Population.

Crouse AL, De Koning L, Sadrzadeh SM, Naugler C.

Arch Pathol Lab Med. 2015 Nov;139(11):1441-5. doi: 10.5858/arpa.2014-0454-OA.

PMID:
26516941
35.

Quantitative proteomics analysis of an ethanol- and a lactate-producing mutant strain of Synechocystis sp. PCC6803.

Borirak O, de Koning LJ, van der Woude AD, Hoefsloot HC, Dekker HL, Roseboom W, de Koster CG, Hellingwerf KJ.

Biotechnol Biofuels. 2015 Aug 5;8:111. doi: 10.1186/s13068-015-0294-z. eCollection 2015.

36.

Associations of total and abdominal adiposity with risk marker patterns in children at high-risk for cardiovascular disease.

de Koning L, Denhoff E, Kellogg MD, de Ferranti SD.

BMC Obes. 2015 Mar 13;2:15. doi: 10.1186/s40608-015-0043-7. eCollection 2015.

37.

Prostate-specific antigen velocity is not better than total prostate-specific antigen in predicting prostate biopsy diagnosis.

Gorday W, Sadrzadeh H, de Koning L, Naugler CT.

Clin Biochem. 2015 Dec;48(18):1230-4. doi: 10.1016/j.clinbiochem.2015.07.008. Epub 2015 Jul 8.

PMID:
26164541
38.

Time-series analysis of the transcriptome and proteome of Escherichia coli upon glucose repression.

Borirak O, Rolfe MD, de Koning LJ, Hoefsloot HC, Bekker M, Dekker HL, Roseboom W, Green J, de Koster CG, Hellingwerf KJ.

Biochim Biophys Acta. 2015 Oct;1854(10 Pt A):1269-79. doi: 10.1016/j.bbapap.2015.05.017. Epub 2015 Jun 4.

39.

TIPIN depletion leads to apoptosis in breast cancer cells.

Baldeyron C, Brisson A, Tesson B, Némati F, Koundrioukoff S, Saliba E, De Koning L, Martel E, Ye M, Rigaill G, Meseure D, Nicolas A, Gentien D, Decaudin D, Debatisse M, Depil S, Cruzalegui F, Pierré A, Roman-Roman S, Tucker GC, Dubois T.

Mol Oncol. 2015 Oct;9(8):1580-98. doi: 10.1016/j.molonc.2015.04.010. Epub 2015 May 9.

40.

Comprehensive Two-Dimensional Liquid Chromatography with Stationary-Phase-Assisted Modulation Coupled to High-Resolution Mass Spectrometry Applied to Proteome Analysis of Saccharomyces cerevisiae.

Vonk RJ, Gargano AF, Davydova E, Dekker HL, Eeltink S, de Koning LJ, Schoenmakers PJ.

Anal Chem. 2015;87(10):5387-94. doi: 10.1021/acs.analchem.5b00708. Epub 2015 May 5.

PMID:
25894977
41.

Temperature Dependence of the Proteome Profile of the Psychrotolerant Pathogenic Food Spoiler Bacillus weihenstephanensis Type Strain WSBC 10204.

Stelder SK, Mahmud SA, Dekker HL, de Koning LJ, Brul S, de Koster CG.

J Proteome Res. 2015 May 1;14(5):2169-76. doi: 10.1021/pr501307t. Epub 2015 Apr 22.

PMID:
25853650
42.

Post-polymerization photografting on methacrylate-based monoliths for separation of intact proteins and protein digests with comprehensive two-dimensional liquid chromatography hyphenated with high-resolution mass spectrometry.

Vonk RJ, Wouters S, Barcaru A, Vivó-Truyols G, Eeltink S, de Koning LJ, Schoenmakers PJ.

Anal Bioanal Chem. 2015 May;407(13):3817-29. doi: 10.1007/s00216-015-8615-4. Epub 2015 Mar 24.

43.

ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels.

Rondeau S, Vacher S, De Koning L, Briaux A, Schnitzler A, Chemlali W, Callens C, Lidereau R, Bièche I.

Br J Cancer. 2015 Mar 17;112(6):1059-66. doi: 10.1038/bjc.2015.60.

44.

Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada.

Healey R, Patel JL, de Koning L, Naugler C.

Leuk Res. 2015 Apr;39(4):429-34. doi: 10.1016/j.leukres.2015.01.015. Epub 2015 Feb 7.

PMID:
25703352
45.

A classification tree approach for improving the utilization of flow cytometry testing of blood specimens for B-cell non-Hodgkin lymphoproliferative disorders.

Healey R, Naugler C, de Koning L, Patel JL.

Leuk Lymphoma. 2015;56(9):2619-24. doi: 10.3109/10428194.2014.999326. Epub 2015 Mar 6.

PMID:
25651431
46.

Sociodemographic correlates of fecal immunotesting for colorectal cancer screening.

Crouse A, Sadrzadeh SM, de Koning L, Naugler C.

Clin Biochem. 2015 Feb;48(3):105-9. doi: 10.1016/j.clinbiochem.2014.12.004. Epub 2014 Dec 11.

PMID:
25500418
47.

The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.

Montes de Oca R, Gurard-Levin ZA, Berger F, Rehman H, Martel E, Corpet A, de Koning L, Vassias I, Wilson LO, Meseure D, Reyal F, Savignoni A, Asselain B, Sastre-Garau X, Almouzni G.

Mol Oncol. 2015 Mar;9(3):657-74. doi: 10.1016/j.molonc.2014.11.002. Epub 2014 Nov 20.

48.

Reinforcement of Bacillus subtilis spores by cross-linking of outer coat proteins during maturation.

Abhyankar W, Pandey R, Ter Beek A, Brul S, de Koning LJ, de Koster CG.

Food Microbiol. 2015 Feb;45(Pt A):54-62. doi: 10.1016/j.fm.2014.03.007. Epub 2014 Mar 18.

PMID:
25481062
49.

Duration of obesity and overweight and risk of type 2 diabetes among US women.

Hu Y, Bhupathiraju SN, de Koning L, Hu FB.

Obesity (Silver Spring). 2014 Oct;22(10):2267-73. doi: 10.1002/oby.20851. Epub 2014 Jul 31.

50.

Association of sociodemographic factors and prostate-specific antigen (PSA) testing.

Gorday W, Sadrzadeh H, de Koning L, Naugler C.

Clin Biochem. 2014 Nov;47(16-17):164-9. doi: 10.1016/j.clinbiochem.2014.08.006. Epub 2014 Aug 14.

PMID:
25130956

Supplemental Content

Loading ...
Support Center